(Q53215151)

12 May 2018

title

CTLA-4 polymorphisms are not associated with ocular inflammatory disease. (English)

1 reference

12 May 2018

author

Philip I. Murray

10

1 reference

12 May 2018

author name string

L Bye

1

1 reference

12 May 2018

N Modi

2

1 reference

12 May 2018

M R Stanford

3

1 reference

12 May 2018

E Kondeatis

4

1 reference

12 May 2018

R Vaughan

5

1 reference

12 May 2018

F Fortune

6

1 reference

12 May 2018

C Kanawati

7

1 reference

12 May 2018

E Ben-Chetrit

8

1 reference

12 May 2018

M Ghabra

9

1 reference

12 May 2018

G R Wallace

11

1 reference

12 May 2018

publication date

20 May 2008

1 reference

12 May 2018

published in

Tissue Antigens

1 reference

12 May 2018

volume

72

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

49-53

1 reference

12 May 2018

cites work

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

A molecular perspective of CTLA-4 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Reversal of the TCR stop signal by CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

CTLA4 gene polymorphism and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Whole-genome screening for susceptibility genes in multicase families with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Cytokine gene polymorphism in sympathetic ophthalmia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Behçet's disease as an autoinflammatory disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2008.01062.X

10.1111/J.1399-0039.2008.01062.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018